MEMBER LOGIN  
MEMBER LOGIN  

Clinical Trials Group

THANZ members are currently participating in the following clinical trials.

CTG Terms of Reference

  • ACAT

    The ACAT Study is a combined prospective observational registry and randomised Phase II interventional study for patients with active cancer and acute vein thrombosis who require anticoagulation. This is an investigator-initiated study of the THANZ (Tim Brighton and Vivien Chen from THANZ, and Liz Hovey Medical Oncologist POWH). 

    Read More
  • Asia Pacific Microangiopathic Thrombocytopenia (APMAT)

    Microangiopathic thrombocytopenia (MAT) is a rare but complex disease family and has a high mortality rate, at 90%, when left untreated.

    Read More
  • TWISTER

    The TWISTER Study (Two Weeks of Low Molecular Weight Heparin for Isolated Symptomatic Distal Vein
    Thrombosis) is a multi-centre Australasian study examining an abbreviated duration of anticoagulation for first episodes of symptomatic distal deep vein thrombosis (IDDVT); planned sample size 330.

    Read More
  • SPRITE

    This study aims to assess the efficacy and safety of using Eltrombopag in patients with early refractory
    ITP.

    Read More